Drug Profile
L 708738
Latest Information Update: 25 Oct 2018
Price :
$50
*
At a glance
- Originator Merck Frosst
- Class Antiasthmatics
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma